Pulmatrix Announces Publication On Physiologically Based Pharmacokinetic Modelling Of Potential Drug-Drug Interactions With PUR1900, Orally Inhaled Itraconazole
Benzinga Newsdesk 3 years ago
BiotechNewsGeneral
Results demonstrate a low likelihood of clinically meaningful drug-drug interactions when PUR1900 is administered with medications contraindicated with oral itraconazolePulmatrix is currently enrolling patients in a
Results demonstrate a low likelihood of clinically meaningful drug-drug interactions when PUR1900 is administered with medications contraindicated with oral itraconazole
Pulmatrix is currently enrolling patients in a Phase 2 study of PUR1900 in adults with ABPA and Asthma